Thus, a fundamental mechanism of pancreatic cancer cell survival has been unveiled, and since the activity of PKCε in pancreatic cancer cells is regulated by inhibitors and metabolites of 5-Lox, these findings opened a new research avenue for understanding the activation mechanism of PKCε in pancreatic cancer for therapeutic intervention. The gene discussed is PRKCE; the disease is familial pancreatic carcinoma.